Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis

ConclusionsMeta-analysis showed that ASAs significantly associated with an increased mortality risk in lung cancer patients treated TKIs, but not in patients with esophageal/gastric, colorectal, or kidney cancer. Until further studies confirm these results, caution should be used when administering ASAs and TKIs to patients with lung cancer.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research